[go: up one dir, main page]

MX2018012129A - Proceso de cultivo celular. - Google Patents

Proceso de cultivo celular.

Info

Publication number
MX2018012129A
MX2018012129A MX2018012129A MX2018012129A MX2018012129A MX 2018012129 A MX2018012129 A MX 2018012129A MX 2018012129 A MX2018012129 A MX 2018012129A MX 2018012129 A MX2018012129 A MX 2018012129A MX 2018012129 A MX2018012129 A MX 2018012129A
Authority
MX
Mexico
Prior art keywords
cell culture
culture process
pva
tyrosine
concentration
Prior art date
Application number
MX2018012129A
Other languages
English (en)
Other versions
MX394238B (es
Inventor
Wang Wenge
Figueroa Bruno
Tung LUAN Yen-
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2018012129A publication Critical patent/MX2018012129A/es
Publication of MX394238B publication Critical patent/MX394238B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Un medio de cultivo celular que comprende tirosina a una concentración de al menos 3 mM y alcohol polivinilico (PVA).
MX2018012129A 2016-04-05 2017-03-23 Proceso de cultivo celular MX394238B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662318275P 2016-04-05 2016-04-05
PCT/IB2017/051692 WO2017175086A1 (en) 2016-04-05 2017-03-23 Cell culture process

Publications (2)

Publication Number Publication Date
MX2018012129A true MX2018012129A (es) 2018-12-17
MX394238B MX394238B (es) 2025-03-19

Family

ID=58503669

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018012129A MX394238B (es) 2016-04-05 2017-03-23 Proceso de cultivo celular

Country Status (17)

Country Link
US (2) US20190112572A1 (es)
EP (1) EP3440190B1 (es)
JP (2) JP7253923B2 (es)
KR (1) KR102168981B1 (es)
CN (1) CN109415688B (es)
AU (1) AU2017247701B2 (es)
CA (1) CA3019753C (es)
ES (1) ES2992543T3 (es)
HR (1) HRP20241328T1 (es)
IL (1) IL261999B2 (es)
MX (1) MX394238B (es)
PL (1) PL3440190T3 (es)
RU (1) RU2709378C1 (es)
SG (1) SG11201808356UA (es)
SI (1) SI3440190T1 (es)
WO (1) WO2017175086A1 (es)
ZA (1) ZA201806295B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111748527B (zh) * 2020-05-15 2021-01-29 上海多宁生物科技有限公司 化学成分限定高效补料培养基及其制备方法和应用
CN111676184B (zh) * 2020-05-15 2021-01-29 上海多宁生物科技有限公司 一种由补料培养基共混的基础培养基及其制备方法和应用
KR102864804B1 (ko) * 2020-09-15 2025-09-25 주식회사 엘지화학 세포 배양용 마이크로-캐리어 및 그 제조방법
EP4050090A4 (en) * 2020-09-15 2023-07-26 Lg Chem, Ltd. MICRO-SUPPORT FOR CELL CULTURE AND METHOD FOR PREPARING IT
WO2023077140A2 (en) 2021-11-01 2023-05-04 Vertex Pharmaceuticals Incorporated Stem cell derived pancreatic islet differentiation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS494454B1 (es) * 1970-08-24 1974-02-01
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
EP0494955B1 (en) 1989-10-05 1998-07-15 Optein, Inc. Cell-free synthesis and isolation of novel genes and polypeptides
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
CA2438148A1 (en) 2001-02-15 2002-08-29 Centocor, Inc. Chemically defined medium for cultured mammalian cells
HUE030806T2 (hu) 2002-05-02 2017-05-29 Wyeth Holdings Llc Calicheamicin származék-hordozó konjugátumok
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
EP1812557A4 (en) * 2004-10-29 2009-11-04 Centocor Ortho Biotech Inc COMPOSITIONS OF CHEMICALLY DEFINED MEDIA
RU2486204C2 (ru) * 2005-07-22 2013-06-27 Уай'З Терапьютикс Ко., Лтд. Антитела против сd26 и способы их применения
RU2520810C2 (ru) * 2006-11-08 2014-06-27 Вайет Рационально разработанные среды для культивирования клеток
RU2377295C1 (ru) * 2008-06-11 2009-12-27 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Питательная среда для культивирования клеток млекопитающих
JP6347949B2 (ja) * 2010-04-26 2018-06-27 ノバルティス アーゲー 改良型細胞培養培地
LT3485903T (lt) * 2011-09-23 2023-02-27 Mereo Biopharma 5, Inc. Vegf/ dll4 surišantys agentai ir jų panaudojimas

Also Published As

Publication number Publication date
AU2017247701A1 (en) 2018-10-04
CN109415688A (zh) 2019-03-01
IL261999A (en) 2018-10-31
WO2017175086A1 (en) 2017-10-12
SG11201808356UA (en) 2018-10-30
EP3440190A1 (en) 2019-02-13
ZA201806295B (en) 2019-07-31
JP2022022475A (ja) 2022-02-04
PL3440190T3 (pl) 2024-12-02
CA3019753A1 (en) 2017-10-12
AU2017247701B2 (en) 2022-11-10
RU2709378C1 (ru) 2019-12-17
US20230416674A1 (en) 2023-12-28
JP2019510499A (ja) 2019-04-18
KR20180117189A (ko) 2018-10-26
IL261999B2 (en) 2023-04-01
BR112018070063A2 (pt) 2019-02-12
IL261999B (en) 2022-12-01
SI3440190T1 (sl) 2025-01-31
HRP20241328T1 (hr) 2024-12-20
JP7253923B2 (ja) 2023-04-07
EP3440190B1 (en) 2024-08-28
US20190112572A1 (en) 2019-04-18
CA3019753C (en) 2021-10-26
MX394238B (es) 2025-03-19
KR102168981B1 (ko) 2020-10-22
ES2992543T3 (es) 2024-12-13
CN109415688B (zh) 2022-08-02

Similar Documents

Publication Publication Date Title
MX2018012129A (es) Proceso de cultivo celular.
MX387673B (es) Dispositivos de aislamiento con una matriz de anodo y un catodo de fibra.
AR119878A2 (es) Composiciones y métodos para detectar un contaminante biológico
CA2944476C (en) Azetidine-substituted fluorescent compounds
AR090952A1 (es) Metodos y aparatos para identificar un protocolo de comunicacion usado en un sistema de control de procesos
BR112017008082A2 (pt) composições e métodos para detectar um vírus de rna
MX2017009109A (es) Dispositivo de trampa para insectos y metodo de uso.
AR119997A1 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso
MX376189B (es) Metodos y sistemas para la deteccion rapida de microorganismos con el uso de bacteriofago recombinante.
CO2017011238A2 (es) Anticuerpos anti-c1s humanizados
EA201591926A1 (ru) Способ многоцветной проточной цитометрии для идентификации популяции клеток, в частности мезенхимальных стволовых клеток
MX2016013877A (es) Composiciones y metodos para mejorar y/o predecir la amplificacion de adn.
MX2016013631A (es) Celulas huespedes modificadas y usos de las mismas.
EP3420072A4 (en) CELL CULTURE MEDIUM
CL2017003309A1 (es) Métodos de purificación y/o inactivación viral
GB2545850A (en) System and method using a combined modality optical probe
ATE533173T1 (de) Vakuumkupplung mit mehreren rillen
AR108059A1 (es) Dispositivo
MX383963B (es) Medios microbiológicos de crecimiento y métodos de utilización de los mismos.
CL2018002522A1 (es) Método de cuantificación de pureza de muestras de partículas subvisibles
TW201614507A (en) Methods and devices for finding settings to be used in relation to a sensor unit connected to a processing unit
WO2019144050A3 (en) Methods of performing digital nucleic acid amplification using polybutene
UY35692A (es) Proceso para la producción de ácido metacrílico y derivados del mismo, microorganismos y medios de fermentación para dicho proceso
EP2757159A3 (en) Microorganism detecting system and microorganism detecting method
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus